EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H16ClF3N4O3 |
| Net Charge | 0 |
| Average Mass | 464.831 |
| Monoisotopic Mass | 464.08630 |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 |
| InChI | InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) |
| InChIKey | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | ferroptosis inducer Any substance that induces or promotes ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms. EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine. anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. tyrosine kinase inhibitor Any protein kinase inhibitor that interferes with the action of tyrosine kinase. |
| Applications: | hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. renoprotective agent Any compound that is able to prevent damage to the kidneys. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. anticoagulant An agent that prevents blood clotting. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sorafenib (CHEBI:50924) has role angiogenesis inhibitor (CHEBI:48422) |
| sorafenib (CHEBI:50924) has role anticoagulant (CHEBI:50249) |
| sorafenib (CHEBI:50924) has role anticoronaviral agent (CHEBI:149553) |
| sorafenib (CHEBI:50924) has role antihypertensive agent (CHEBI:35674) |
| sorafenib (CHEBI:50924) has role antineoplastic agent (CHEBI:35610) |
| sorafenib (CHEBI:50924) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925) |
| sorafenib (CHEBI:50924) has role ferroptosis inducer (CHEBI:173085) |
| sorafenib (CHEBI:50924) has role hypoglycemic agent (CHEBI:35526) |
| sorafenib (CHEBI:50924) has role renoprotective agent (CHEBI:231911) |
| sorafenib (CHEBI:50924) has role tyrosine kinase inhibitor (CHEBI:38637) |
| sorafenib (CHEBI:50924) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| sorafenib (CHEBI:50924) is a aromatic ether (CHEBI:35618) |
| sorafenib (CHEBI:50924) is a monochlorobenzenes (CHEBI:83403) |
| sorafenib (CHEBI:50924) is a phenylureas (CHEBI:134043) |
| sorafenib (CHEBI:50924) is a pyridinecarboxamide (CHEBI:25529) |
| Incoming Relation(s) |
| sorafenib tosylate (CHEBI:50928) has part sorafenib (CHEBI:50924) |
| IUPAC Name |
|---|
| 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide |
| INNs | Source |
|---|---|
| sorafenib | WHO MedNet |
| sorafenib | WHO MedNet |
| sorafénib | WHO MedNet |
| sorafenibum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide | ChemIDplus |
| BAY-43-9006 | ChEMBL |
| N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea | ChemIDplus |
| Citations |
|---|